Cigna: Shares Marching To Full Recovery
Cigna Group's stock is rated as a 'Buy' following strong first-quarter results and increased guidance. The company's pharmacy and behavioral health segments are contributing to revenue growth, despite some temporary earnings impacts from divestitures and PBM reform. Shares are currently trading at a significant discount, suggesting potential for substantial returns in the coming years.
- ▪Cigna's Q1 2026 results were strong, leading to a 'Buy' rating.
- ▪The pharmacy and behavioral health segments are driving revenue growth.
- ▪Shares are trading at a 25% discount to a fair value estimate of $377.
Seeking Alpha files mainly under finance. We currently carry 5,907 of its stories.
Opening excerpt (first ~120 words) tap to expand
{"@context":"https://schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://seekingalpha.com/"},{"@type":"ListItem","position":2,"name":"Dividends Analysis","item":"https://seekingalpha.com/dividends"},{"@type":"ListItem","position":3,"name":"Dividend Ideas","item":"https://seekingalpha.com/dividends/dividend-ideas"},{"@type":"ListItem","position":4,"name":"Healthcare ","item":"https://seekingalpha.com/stock-ideas/healthcare"}]}{"@context":"https://schema.org","@type":"NewsArticle","mainEntityOfPage":{"@type":"WebPage","@id":"https://seekingalpha.com/article/4904807-cigna-shares-marching-to-full-recovery"},"author":{"@type":"Person","name":"Treading…
Excerpt limited to ~120 words for fair-use compliance. The full article is at Seeking Alpha.
Discussion
0 commentsMore from Seeking Alpha
